These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 671234)

  • 1. Controlled delivery of theophylline: chemistry of 7-acyl- and 7,7'-acylditheophylline derivates.
    Bodor N; Sloan KB; Kuo YN; Higuchi T
    J Pharm Sci; 1978 Aug; 67(8):1045-50. PubMed ID: 671234
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hydrolysis and dissolution behavior of a prolonged-release prodrug of theophylline: 7,7'-succinylditheophylline.
    Lee HK; Lambert H; Stella VJ; Wang D; Higuchi T
    J Pharm Sci; 1979 Mar; 68(3):288-95. PubMed ID: 34020
    [No Abstract]   [Full Text] [Related]  

  • 3. [Metabolism of 7-(3-butynyl) theophylline in rats (author's transl)].
    Reisch J; Seeger U
    Arch Pharm (Weinheim); 1977 Nov; 310(11):888-93. PubMed ID: 931577
    [No Abstract]   [Full Text] [Related]  

  • 4. Effect of pH on the in vitro dissolution and in vivo absorption of controlled-release theophylline in dogs.
    Vashi VI; Meyer MC
    J Pharm Sci; 1988 Sep; 77(9):760-4. PubMed ID: 3225770
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of gastroretentive microspheres and sustained-release preparations using theophylline pharmacokinetics.
    Miyazaki Y; Yakou S; Takayama K
    J Pharm Pharmacol; 2008 Jun; 60(6):693-8. PubMed ID: 18498704
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Per-oral controlled release dosage form of theophylline using soybean protein.
    Machida Y; Tokumura T; Nagai T
    Drug Des Deliv; 1987 Feb; 1(3):187-92. PubMed ID: 3509332
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Bioavailability of theophylline in a new oral sustained-release preparation (author's transl)].
    Schneider GF; Heese GU; Huber HJ; Janzen N; Jünger H; Moser C; Stanislaus F
    Arzneimittelforschung; 1981; 31(9):1489-97. PubMed ID: 7197962
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stability of theophylline elimination rate.
    Milavetz G; Vaughan LM; Weinberger MM
    Clin Pharmacol Ther; 1987 Apr; 41(4):388-91. PubMed ID: 3549119
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Bioavailability of 3 theophylline delayed-release preparations. Comparison of theophylline concentrations in the serum and saliva in the steady state].
    Bochsler HP; Meyer UA
    Schweiz Med Wochenschr; 1982 Nov; 112(47):1702-10. PubMed ID: 7178872
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Prolongation of theophylline derivative release with cellulose acetate based tablets].
    Guyonnet T; Brossard C; Lefort des Ylouses D
    J Pharm Belg; 1990; 45(2):111-9. PubMed ID: 2355304
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Comparative bioavailability of 2 oral theophylline sustained-release preparations].
    Tritthart W; Lücker PW; Fáy E; Buchebner J
    Arzneimittelforschung; 1983; 33(11):1603-6. PubMed ID: 6686457
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Delay in the absorption rate of theophylline from a sustained release theophylline preparation caused by food.
    Pedersen S
    Br J Clin Pharmacol; 1981 Dec; 12(6):904-5. PubMed ID: 7340892
    [No Abstract]   [Full Text] [Related]  

  • 13. Theophylline bioavailability following oral administration of six sustained-release preparations.
    Spangler DL; Kalof DD; Bloom FL; Wittig HJ
    Ann Allergy; 1978 Jan; 40(1):6-11. PubMed ID: 623398
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Influence of food on the bioavailability of theophylline in a delayed-release dosage form (Dilatrane AP)].
    Flouvat B; Delhotal-Landes B; Boutin-Pannetier MS
    Therapie; 1986; 41(2):144-5. PubMed ID: 3726788
    [No Abstract]   [Full Text] [Related]  

  • 15. Relative bioavailability and release pattern of whole and halved sustained-release theophylline tablets.
    Leeds NH; Gal P; Purohit AA; Walter JB
    Clin Pharm; 1982; 1(2):163-4. PubMed ID: 7185516
    [No Abstract]   [Full Text] [Related]  

  • 16. [Studies on the sustained-release theophylline tablet].
    Mao FF; Tu XD; Zhu JB; Zhu YP
    Yao Xue Xue Bao; 1986 Mar; 21(3):213-9. PubMed ID: 3788587
    [No Abstract]   [Full Text] [Related]  

  • 17. In vivo evaluation of a theophylline oral controlled-release unit dosage form.
    Gangadharan B; Ritschel WA; Hussain SA
    Arzneimittelforschung; 1987 Nov; 37(11):1256-7. PubMed ID: 3440033
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis and Evaluation as a Blood-Brain Barrier-Permeable Probe of 7-N-(PROXYL-3-yl-methyl)theophylline.
    Emoto MC; Sasaki K; Maeda K; Fujii HG; Sato S
    Chem Pharm Bull (Tokyo); 2018; 66(9):887-891. PubMed ID: 30175747
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bioavailability and in vivo release behavior of controlled-release multiple-unit theophylline dosage forms in beagle dogs, cynomolgus monkeys, and göttingen minipigs.
    Ikegami K; Tagawa K; Osawa T
    J Pharm Sci; 2006 Sep; 95(9):1888-95. PubMed ID: 16850398
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of a high fat breakfast on the bioavailability of theophylline controlled-release formulations: an in vitro demonstration of an in vivo observation.
    Maturu PK; Prasad VK; Worsley WN; Shiu GK; Skelly JP
    J Pharm Sci; 1986 Dec; 75(12):1205-6. PubMed ID: 3559932
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.